Lunai Bioworks Inc. SEC filings LNAI

Lunai Bioworks Inc. has 599 filings in SEC EDGAR's recent list, going back to Aug 12, 2011. Its latest annual report, Form 10-K, was filed on Oct 13, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (listing notice, officer or director change, regulation fd disclosure, other events). The company's fiscal year ends on June 30.

Form Description Filed Period
10-K Annual report Oct 13, 2026 Jun 30, 2026
10-K Annual report Sep 29, 2025 Jun 30, 2025
10-K/A Amended annual report Feb 19, 2025 Jun 30, 2024
10-K/A Amended annual report Oct 28, 2024 Jun 30, 2024
10-K Annual report Oct 10, 2024 Jun 30, 2024
10-K/A Amended annual report Oct 30, 2023 Jun 30, 2023
10-K Annual report Oct 2, 2023 Jun 30, 2023
10-K Annual report Feb 27, 2023 Jun 30, 2022
10-K/A Amended annual report Oct 28, 2021 Jun 30, 2021
10-K Annual report Sep 24, 2021 Jun 30, 2021
10-K/A Amended annual report Oct 28, 2020 Jun 30, 2020
10-K Annual report Sep 23, 2020 Jun 30, 2020
10-K/A Amended annual report Oct 28, 2019 Jun 30, 2019
10-K Annual report Sep 30, 2019 Jun 30, 2019
10-K/A Amended annual report Oct 29, 2018 Jun 30, 2018
10-K Annual report Oct 1, 2018 Jun 30, 2018
10-K/A Amended annual report Nov 20, 2017 Jun 30, 2017
10-K Annual report Sep 29, 2017 Jun 30, 2017
10-K Annual report Sep 28, 2016 Jun 30, 2016
10-KT Transition report Sep 28, 2015 Jun 30, 2015
10-K Annual report Mar 31, 2015 Dec 31, 2014
10-K Annual report Jul 16, 2013 Mar 31, 2013
10-K Annual report Jul 17, 2012 Mar 31, 2012

Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LNAI (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Suite 906 Los Angeles, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1527728
Former names
RENOVARO INC. (until Aug 26, 2025); RENOVARO BIOSCIENCES INC. (until Feb 7, 2024); Enochian Biosciences Inc (until Aug 1, 2023); DanDrit Biotech USA, Inc. (until Feb 23, 2018); Putnam Hills Corp. (until Feb 11, 2014)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.